CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Exit or restructuring costs
- 8-K Event Other events
- 4 Open-market sale SVP, CFO sold 8,186 shares at an average $1.65 ($13,527)
- 4 Open-market sale EVP, Chief Legal Officer sold 8,672 shares at an average $1.65 ($14,330)
- 4 Open-market sale President and CEO sold 30,766 shares at an average $1.65 ($50,835)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 15,126 shares at an average $1.65 ($24,997)
- 4 Open-market sale EVP, Chief Medical Officer sold 6,975 shares at an average $1.65 ($11,526)
- 4 Open-market sale EVP, Global Head RA & Quality sold 3,346 shares at an average $1.65 ($5,531)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 14,291 shares at $1.66 ($23,723)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 57 · 1,133 filings